Int. J. Mol. Sci. 2011, 12(7), 4465-4476; doi:10.3390/ijms12074465
Review

Epigenetic Therapy for Breast Cancer

1email, 1email, 1email, 2email, 1email and 1,* email
Received: 20 May 2011; in revised form: 30 June 2011 / Accepted: 1 July 2011 / Published: 11 July 2011
(This article belongs to the Section Molecular Pathology)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Both genetic and epigenetic alterations can control the progression of cancer. Genetic alterations are impossible to reverse, while epigenetic alterations are reversible. This advantage suggests that epigenetic modifications should be preferred in therapy applications. DNA methyltransferases and histone deacetylases have become the primary targets for studies in epigenetic therapy. Some DNA methylation inhibitors and histone deacetylation inhibitors are approved by the US Food and Drug Administration as anti-cancer drugs. Therefore, the uses of epigenetic targets are believed to have great potential as a lasting favorable approach in treating breast cancer.
Keywords: breast cancer; epigenetic therapy; DNA methylation inhibitors; Histone deacetylation inhibitors
PDF Full-text Download PDF Full-Text [168 KB, Updated Version, uploaded 19 June 2014 03:53 CEST]
The original version is still available [134 KB, uploaded 19 June 2014 03:53 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Cai, F.-F.; Kohler, C.; Zhang, B.; Wang, M.-H.; Chen, W.-J.; Zhong, X.-Y. Epigenetic Therapy for Breast Cancer. Int. J. Mol. Sci. 2011, 12, 4465-4476.

AMA Style

Cai F-F, Kohler C, Zhang B, Wang M-H, Chen W-J, Zhong X-Y. Epigenetic Therapy for Breast Cancer. International Journal of Molecular Sciences. 2011; 12(7):4465-4476.

Chicago/Turabian Style

Cai, Feng-Feng; Kohler, Corina; Zhang, Bei; Wang, Ming-Hong; Chen, Wei-Jie; Zhong, Xiao-Yan. 2011. "Epigenetic Therapy for Breast Cancer." Int. J. Mol. Sci. 12, no. 7: 4465-4476.


Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert